Warberg Asset Management’s MEDIROM Healthcare Technologies MRM Stock Holding History

Warberg Asset Management’s Portfolio MRM Stock Details MRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,919	Closed	-$23.6K	–	210
2024 Q4	$23.6K	Buy	+22,919	New	+$57.1K	﹤0.01%	150

Other funds holding MRM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Warberg Asset Management's MRM Position: Q1 2025 in Review

Warberg Asset Management sold out of MEDIROM Healthcare Technologies (MRM) in Q1 2025, closing a stake of 22,919 shares — an estimated $23.6K sold.

Warberg Asset Management first reported a position in MRM in Q4 2024 and held it in 1 quarter. The position peaked at $23.6K in Q4 2024. 3 funds tracked by Wall St. Rank hold MRM as of Q1 2025.

Warberg Asset Management reported no remaining MEDIROM Healthcare Technologies position as of Q1 2025 after selling out during the quarter.
Warberg Asset Management sold 22,919 MEDIROM Healthcare Technologies shares in Q1 2025, an estimated $23.6K.
Warberg Asset Management first reported a position in MEDIROM Healthcare Technologies in Q4 2024 and held it in 1 quarter.
Warberg Asset Management's MEDIROM Healthcare Technologies position peaked at $23.6K in Q4 2024.
3 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q1 2025.

Based on Warberg Asset Management's 13F filing for Q1 2025, filed 9 May 2025.